Copyright
        ©The Author(s) 2016.
    
    
        World J Gastroenterol. Dec 14, 2016; 22(46): 10093-10102
Published online Dec 14, 2016. doi: 10.3748/wjg.v22.i46.10093
Published online Dec 14, 2016. doi: 10.3748/wjg.v22.i46.10093
            Table 1 Evidence supporting a role for probiotics in treating gastrointestinal symptoms in autism spectrum disorders
        
    | Clinical symptoms | Ref. | 
| Children with ASD have an abnormal fecal microbiota | [28,35,48,51,54,98-100] | 
| GI symptoms common in ASD are similar to those in IBS | [11,12] | 
| IBS also is associated with an abnormal fecal microbiota | [61,62,101] | 
| Meta-analysis shows IBS symptoms are improved by probiotic treatment. (Preliminary evidence suggests potential benefits in ASD in children and rodents models.) | [65,72,102-104] | 
| Mild inflammation in the GI tact may be seen in children with ASD. (There is evidence to support or refute this contention: abnormal duodenal and ileal biopsies and high plasma S100A9 but normal fecal calprotectin and lactoferrin levels) | [19,22-26,31,37] | 
| Probiotics reduce gut inflammation (Shown in animal models and in human diseases) | [70,105-108] | 
| Systemic inflammation can be also seen in children with ASD | [18,109-111] | 
| Immune modulation of children with ASD may reduce clinical symptoms | [41,112] | 
- Citation: Navarro F, Liu Y, Rhoads JM. Can probiotics benefit children with autism spectrum disorders? World J Gastroenterol 2016; 22(46): 10093-10102
- URL: https://www.wjgnet.com/1007-9327/full/v22/i46/10093.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i46.10093

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                        